Clinical Trials Directory

Trials / Completed

CompletedNCT01720758

Assessment of the V600E Mutation in the B-RAF Gene in Chronic Lymphoproliferative Disease

Assessment of the V600E Mutation in the B-RAF Gene in Chronic Lymphoproliferative Disease.

Status
Completed
Phase
Study type
Observational
Enrollment
20 (actual)
Sponsor
HaEmek Medical Center, Israel · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The presence of a specific mutation in the gene known as B-RAF has been found in patients who have Hairy Cell Leukemia. In this study this specific mutation known as V600E will be ascertained in peripheral blood samples of patients who have this disease and in a group of patients who have a similar chronic lymphoproliferative conditions such as splenic marginal lymphoma. The finding of this specific mutation will help to verify or exclude the diagnosis of Hairy Cell Leukemia and determine whether patients are in remission.

Conditions

Timeline

Start date
2012-11-01
Primary completion
2013-03-01
Completion
2013-04-01
First posted
2012-11-02
Last updated
2017-08-11

Source: ClinicalTrials.gov record NCT01720758. Inclusion in this directory is not an endorsement.

Assessment of the V600E Mutation in the B-RAF Gene in Chronic Lymphoproliferative Disease (NCT01720758) · Clinical Trials Directory